Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$1,630,519
-15.51%
Shares
Shares Volume: 50,716 Shares
Average Share Price: $32.15
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Nov 5 2024
traded on Nov 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 276,286 |
| PURCHASES/SALES 1Y | 0 / 14 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $320,152.37 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 2 / 41 |
| P/S VALUE RATIO | 0.145 |
| AVERAGE SALE VALUE | $618,340.87 |
| COMPANY PREVIOUS TRADES |